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find predictive factors of improvement of physical ability in HF-REF patients
after completion of an exercise training program.
Methods Functional, clinical, biological and echocardiographic data, were
retrospectively analysed in 50 HF-REF patients who underwent an exercise
training program in our center in 2013. The improvement of physical abilities
was defined by an increase of 1 or more metabolic equivalent (MET) between
the first and the final exercise testing.
Results Patients were 58.3±12.1 years old with a mean ejection fraction of
34±10% and an average of 18.7 sessions over a 4 month period was per-
formed. Mean pre and post training MET were respectively 4.9±1.6 and
6.1±2.3 (p<0.001). At the end of the training period, 22 patients displayed an
improved exercise testing. Exercise testing improvement was associated with
the absence of arterial hypertension (57% versus 27% p=0.04), and a tendency
was seen with lower furosemide daily intake (25.7mg versus 84.3mg p=0.05),
and lower Heart Failure Risk of Death at 1 year calculation (7.02% versus
10.22% p=0.05). Pre-training exercise capacity was not associated with post-
training improvement (4.6±1.5 MET versus 5.2±1.8 MET p=0.17).
Conclusion HF-REF patients without previous arterial hypertension had
more chance to improve physical capacities after exercise training program.
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Background The use of 6-minute walk test for assessing the functional
status capacity of patients with chronic heart failure is commonly applied as
prognostic gauges for systolic HF patients. The aim of study was to verify the
impact of 6MWD in patients with chronic heart failure (CHF) and to analyze
the relation between clinical and echocardiographic data and the 6 minutes
walk test (6MWT) in patients with chronic systolic heart failure.
Methods and results 814 patients (age 63years, 68% males) with CHF
underwent a six-minute walk test in a therapeutic unit of heart failure. Clinical
data, biological and echocardiographic parametres were campared. We divided
patients for 3 groups: group 1: 6MWD <300m (n=740), group 2:
300<6MWD<450 m (n=54) and group 3: 6MWD >450m (n=20). 154 patients
(19%) were in NYHA functionnal class III: 96% (n=148) patients in group 1,
3% (n=5) in group2 and 1% (n=1) in group 3 (p=0.04). 
Age, hypertension, diabetes, dyslipidemia, Ischemic heart disease, strock
attack did not differ among the groups. However male sex, diastolic dysfunc-
tion (p=0.01), right ventricular systolic dysfunction (p<0.0001), hospitalisza-
tion rate for cardiac decompensation (p<0.0001), high heart rate were higher
in the group with 6MWF <300 m. 
Conclusion In systolic heart failure outpatients, lower functional capacity
during six minute walk is associated with more hospitalizations for cardiac
decompensation, more diastolic dysfunction and right ventricular systolic dys-
function with good correlation with NYHA functionnal class.
Keywords six-minute walk, functional capacity, chronic heart failure,
NYHA functional class, diastolic function.
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Background Heart failure (HF) is a common public health problem. The
neurohormonal blockade modifies this natural history; however, it is often
suboptimal. Our objective is to appraise the effectiveness of beta blockers and
angiotensin-converting enzyme inhibitor (ACEI) in patients with heart failure
and to assess at what percentage we used them to treating HF at target doses.
Methods and results We evaluated medication use in a retrospective cohort
of 1841 outpatients followed in therapeutic unit of heart failure for heart failure
with reduced ejection fraction. We divided patients on 2 groups: group 1 with
cardiac decompensation (n=497, 27%), group 2 with compensated heart failure
(n=1344, 73%). The mean age of patients was 65 years with SBP =117.63 in
group 1 and 129.4 in group 2, HR =89.3 in group 1, 61.5 bpm in group 2 and
sinus rhythm (86.52%). As for treatment, 47% (235/497) in group 1 received a
beta-blocker vs 86.75% (1166/1344) in group 2 (p=0.0001) and 85.51% (425/
497) in group 1 received ACEI vs 88.61% (1191/1344) in group 2 (p=0.34). As
for the doses: 6.63% (33/497) in group 1 received an optimal dose of beta-
blocker vs 23% (311/1344) in group 2 and 22% (109/497) in group 1 had an
optimized dose of ACEI vs 34.44% (463/1344) in group 2 (p=0.0001).
Conclusion In conclusion, the use of beta blockers and ACEI at target
doses is associated with a decreased risk of hospitalization for HF in patients
with systolic dysfunction.
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Objective identifying and measuring predictors of one-year mortality in
newly diagnosed chronic systolic heart failure.
Methods we conducted a longitudinal prospective analytical bi -centric
study, with one year follow-up.
Results 206 patients were enrolled with a mean age of 54.9±1.8 years, a sex
ratio of 1.9. The prevalence of diabetes mellitus was 39.8%, hypertension 30.1%.
Coronary artery disease was present in 50.5%, dilated cardiomyopathy in 30.1%
and toxic cardiomyopathy in 1.9%. The mortality rate was 12.7% (11.7% in men
vs 14.2% in women, p not significant) and re-admission rate was 17.6% (23,1%
for men vs 6,6% in women, p=0.004). Most clinical, echographic, biological and
functional parameters cited in the literature have demonstrated prognostic predic-
tive value with different rates of sensitivity and specificity. In multivariate anal-
ysis, pulmonary vascular resistance (new highly sensitive and specific parameter,
RR 47), BNP, TAPSE, dP/dt, the distance travelled in six-minutes’ walk test and
serum sodium level were predictors of mortality in heart failure. The median sur-
vival by Kaplan- Meier was 24 months, with no gender difference. All parameters
influencing mortality had an impact on survival. Improving the quality of life as
measured by the six minutes’ walk test and the MINNESOTA questionnaire was
significantly improved in patients remained alive. 
Conclusion the evaluation of drug prescriptions trends, according to new
international guidelines, is quite reassuring in that the new molecules that
allowed a significant reduction in morbidity and mortality in heart failure are
widely prescribed in our patients.
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Context Non ischemic dilated cardiomyopathies (NICM) constitute a wide
group of cardiac diseases, which don’t have an identical evolution and outcome.
The diagnosis of NICM is usually based on the results of a trans-thoracic echocar-
diogram (TTE) and a coronary angiography (CA). Knowledge of their specific
